Navigation Links
Living Proof, Inc.: The Launch of the Next Beauty Revolution
Date:10/7/2008

NEW YORK, Oct. 7 /PRNewswire/ -- Living Proof, a technology-based beauty company from Cambridge, Massachusetts, announced today its first product introduction, No Frizz -- a line of silicone-free, frizz-eliminating hair products based upon entirely new science developed by the company. The Living Proof team of scientists is led by Dr. Robert Langer, founder of Langer Labs and an Institute Professor at MIT.

Founded by Dr. Langer, one of the world's top biomedical scientists, and Polaris Venture Partners, a venture capital firm with an extraordinary 25-year track record of business development, Living Proof stands to revolutionize the beauty industry. Its unique approach to the category is to launch breakthrough hair and skin products with newly-invented materials that work dramatically better than anything else in the market today.

"We saw most of the industry using the same basic ingredients and spending millions to try to differentiate their largely similar products," explained Jon Flint, co-founder of Polaris Venture Partners. "Our point of difference is to approach beauty problems from an outsider's perspective, using the resources you would typically find in a venture-backed bio-pharma startup."

To achieve their vision, Living Proof assembled a scientific team with experience outside of beauty that could break new ground, without any preconceived notions of what could and could not be done. This team spent more than three years assessing new molecules that have been used in the past in medical applications, but never in the beauty industry. The scientists, with guidance from industry veterans and business experts, created products that push beyond existing limits to change how we think about beauty today.

With its first launch, No Frizz, Living Proof utilized the expertise of Langer Labs with the discovery of a new molecule, PolyflouroEster. The molecule is smaller than traditional frizz-fighting ingredients, allowing it to pro
'/>"/>

SOURCE Living Proof
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. diaDexus, Inc. and Living Heart Foundation Offer the PLAC(R) Test to Detect Hidden Risk for Heart Attack and Stroke in Retired NFL Players
2. UCB Scholarship Program Awards $300,000 to Students Living with Crohns Disease
3. Touch Bionics acquires LIVINGSKIN
4. Complete Genomics Launches, Becomes Worlds First Large-Scale Human Genome Sequencing Company
5. Simbionix Launches Innovative Patient-Specific Simulation
6. RainDance Technologies Signs a Collaboration Agreement with sanofi-aventis and Louis Pasteur University to Launch dScreen Consortium within ALSACE BIOVALLEY cluster
7. CISBIO Bioassays Launches Chromoa(TM) Chromogranin A ELISA Kit
8. Cyntellect Launches CellXpress(TM) System to Boost Productivity of Biopharmaceutical Process Development
9. Histogen Launches BioNuesis, the Only All-Human Stem Cell Culturing Kit
10. Sigma-Aldrich Launches Breakthrough Genome-Editing Tools
11. Lena Chow, Veteran Biotech Marketer, Launches New Website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... CALGARY, Dec. 2 /PRNewswire-FirstCall/ - Oncolyti...SX:ONC; NASDAQ: ONCY ) announced today that in con...g, the underwriters have exercised in full their o...37,500 units. Each unit is comprised of one common... and was sold at a price of US$3.00 per unit. Each...
(Date:12/2/2009)... JERUSALEM, Israel, December 2 Gamida Cell an...reclinical (animal study) safety and,efficacy of a...om Weill,Cornell Medical College and Gamida Cell. ...anemias such as Cooley,s Anemia. , Gamida Cell... ex vivo,populations of stem/progenitor cells. The...
(Date:12/2/2009)... CITY, Dec. 2 /PRNewswire-FirstCall/ - AEterna Zen...y"), a global biopharmaceutical company focused on...hat the U.S. Food and Drug Administration (FDA) ha... PI3K/Akt pathway inhibitor compound, perifosine (...y multiple myeloma. Keryx Biopharmaceuticals, Inc....
(Date:12/1/2009)... Dr. Kerry Solomon announced that he ...nched his redesigned website at www.DrKerrySolomo...Group. Dr. Solomon is a proven LASIK, lens implan...sionally recognized for his substantial contributi... a member of Trusted LASIK Surgeons, which screens...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6
..., March 13 /PRNewswire-FirstCall/ -- DOR BioPhar...mpany) announced today that it has appointed Brian...d Chief Medical Officer. Dr. Hamilton is a recogni...ally active steroids as well as in Graft-versus-Ho...shed career of more than 25 years in both academia...
... Some of the world,s most respected e...security questions during a daylong gathering in H...eater Houston Partnership once again takes center ...hosting "America,s Energy Future: Assessing O... Houston (PRWEB) March 13, 2009 -- Pres...
... N.J., March 12 Schering-Plough Corporation (NYSE...arnings results for the 2009 first quarter on Tues...that day, Schering-Plough will conduct a conferenc...r. Fred Hassan, Schering-Plough,s chairman and CE...onference call. , , To listen live to the call, ...
Other Biology Technology:DOR BioPharma Appoints Brian L. Hamilton, MD, PhD as Chief Medical Officer 2DOR BioPharma Appoints Brian L. Hamilton, MD, PhD as Chief Medical Officer 3DOR BioPharma Appoints Brian L. Hamilton, MD, PhD as Chief Medical Officer 4DOR BioPharma Appoints Brian L. Hamilton, MD, PhD as Chief Medical Officer 5Greater Houston Partnership to Lead Energy Security Discussion 2
(Date:12/3/2009)...mes to investment in energy efficient technologies...esearch Council (EPSRC) Chief Executive Dave Delpy...ineering research has already brought us fuel cell...e investment is needed to develop the capabilities...on emission targets by 2020 and limit the impact o...
(Date:12/2/2009)...strengthen the evidence that people who smoke ciga...d risk for developing colorectal cancer, even afte...ides one more reason not to smoke, or to quit as s...un, M.D., M.S., vice president emeritus, epidemiol...er Society. "Colorectal cancer should be added to ...
(Date:12/2/2009)...er-free status did not prompt people participating...cancer screening program to pick up their cigarett...n Cancer Epidemiology, Biomarkers & Prevention , ...esearch. The December issue contains a special foc...espread concern in the lung screening community th...
Breaking Biology News(10 mins):Research is vital to a cleaner, greener, low carbon future 2Cigarette smoking increases colorectal cancer risk 2Repeat negative CT scan for lung cancer does not encourage ex-smokers to resume the habit 2Questions to Pharmacists Rise After Michael Jacksons Death 51194 1Questions to Pharmacists Rise After Michael Jacksons Death 51194 2Universal Health Services Inc Announces Dividend 51192 1Data published in the New England Journal of Medicine support use of raxibacumab 28ABthrax 29 for the treatment of inhalation anthrax 9185 1Data published in the New England Journal of Medicine support use of raxibacumab 28ABthrax 29 for the treatment of inhalation anthrax 9185 2
...ose of chemotherapy drugs to specific cancer cells... may one day be possible thanks to a nanoscale dru... the U.S. Department of Energy,s Ames Laboratory. ...spheres to carry drugs inside living cells, Ames L... methods to control whether or not the particle de...
...ene-coated gold particles protect mice against a p...ers at UT Southwestern Medical Center have found. ...roducing the specific protein ?called amyloid-beta...odies and greatly reduce the protein,s build-up in...ans is a hallmark of Alzheimer,s disease. , "The ...
...hool of Medicine researchers have identified the p...e first line of defense against invading pathogens...site this week and will be published in a future i...re body is formed in the skin by a group of cells ...gens present in the skin and transport them to lym...
Other Biology News:Cellular scale drug delivery from the inside out 2Cellular scale drug delivery from the inside out 3DNA gene vaccine protects against harmful protein of Alzheimer's disease 2Source of crucial immune cell in the skin discovered 2
Feline serum from Equitech-Bio
Donor feline Serum - 500mL from Biomeda Corporation
Paraffin Tissue Section Panel - Monkey (Simian) Normal Tissue, Multi-tissue I from BioChain
Mouse Anti-Rabbit ryanodine receptor, skeletal Monoclonal Antibody, Unconjugated from Developmental Studies Hybridoma Bank
Biology Products: